News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website


Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells


Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)

This study identifies a few promising combinations of readily available drugs.  However, it also shows that it is hard to predict which combinations will work in an individual.  Different cell lines reacted different ways, and sometimes made the tumor grow faster instead of helping.  More research needs to be done but I think this is a step in the right direction.  They may be able to find readily available (and sometimes cheap) drugs that can be added to the standard treatments to make them work much better.


Posted on: 12/24/2018

Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells

 




Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740